Loading...

ZIMLAB Zim Laboratories Ltd Major expansion or diversification plans Announcement

Zm L

ZMLB

Zim Laboratories Ltd

(ZIMLAB)

2025 Announcement

Audited Results Intimation

EU GMP inspection completion

Equity Investment

Regulatory Compliance

Internal Auditor Appointment

Closure of trading window

Reg 29(2 disclosure)

Advisory Board Appointment

Virtual One-to-One

Preferential allotment

Subsidiary dissolution

Credit Rating Reaffirmation

Earnings Call Transcript

Conference Call

Newspaper Publication Discl...

Earnings Presentation

Geographic Expansion

Unaudited Results

Wholly owned subsidiary inv...

Special transfer window

Earnings Conference Call

Appointment of Senior Manag...

Regulatory disclosure

Newspaper Publication

Preferential Issue

Preferential Issue

Policy Amendment

Fundraising via securities

Regulatory Compliance

Trading window closure

Investor Meet (One-to-One)

One-to-One Virtual Meeting

Regulatory approval

Transcript Release

Audio recording (conference...

Newspaper Publication

Earnings Presentation

Unaudited results

Unaudited financial results

Earnings Call Notice

Board Meeting Notice

Postal Ballot Notice

Compliance Certificate

Management Change

Earnings Call Transcript

Earnings Call Recording

Financial Results Publication

Earnings Call Announcement

Management Change

Q1 FY26 Presentation

Subsidiary Closure

Investment Announcement

Price Movement Response

Share Price Clarification

Investor Meeting

Marketing Authorization Gra...

EU GMP Compliance Issue

Transfer Requests Notice

Share Transfer Notice

Marketing Authorization Gra...

Investment Update

Compliance Certificate

Investment Update

Investor Meeting

AGM Announcement

Shareholder Letters

Investor Meet Scheduled

Earnings Call Transcript

Annual General Meeting

Earnings Call Update

Annual Compliance Report

Financial Results Publication

Q4 FY25 Earnings

Management Changes

Earnings Call Scheduled

Investment Update

Cost Auditor Appointment

Compliance Certificate

Collaboration Announcement

Management Change

Equity Investment

Management Changes

Marketing Authorization Gra...

Investment Update

Investor Meeting

Investor Meet Scheduled

Investor Meet Scheduled

Financial Results Published

Earnings Presentation

Marketing Authorization Gra...

Compliance Certificate

Registrar Name Change

Trading Volume Clarification

Investor Meeting Scheduled

Investor Meeting Scheduled

Credit Rating Update

Investor Meeting

New Subsidiary Established

New Subsidiary Incorp.

Earnings Call Transcript

Earnings Call Update

Financial Results Published

Earnings Presentation

Management Changes

Earnings Call Scheduled

Credit Rating Update

SEBI Compliance Update

Investment Update

Equity Investment

Investor Meeting Scheduled

Investor Presentation

Investor Meeting Scheduled

Investors/Analysts Meet

Analyst/Investor Meet

Newspaper Publication

Earnings Presentation

Investment in Subsidiary

Management Change

Marketing Authorization

Dividend Transfer to IEPF

Compliance Certificate Subm...

Investment Update

Investor Meeting

Newspaper Publication

AGM advertisement

Cost Auditor Appointment

Compliance Submission

Earnings Presentation

Financial Investments in Su...

Trading Volume Clarification

Employee Stock Options Grant

Compliance Certificate Subm...

Credit Rating Announcement

Compliance Certificate Subm...

Compliance Certificate Subm...

Investment in ZIMTAS Pty Ltd

Investor Meet Intimation

Meeting Intimation

Investors/Analysts Meet

Investors/Analysts Meet

Earnings Call Recording

Financial Results

Earnings Presentation

Appointment of Secretarial ...

Conference Call

Compliances-Certificate

Investor Meet Schedule

Investor Conferences

Investor Meeting

Investor Conferences

Investors Meet Scheduled

Q2 & H1FY24 Earnings Confer...

Conference Call

Newspaper Publication

Earnings Presentation

Incorporation of Step-Down ...

Compliance Certificate Subm...

Investors/Analysts Meet

Financial Statements

Financial Statements

Financial Statements

Financial Statements

Equity, Debt, VC, Private E...

Asset Acquisitions

Analyst Meeting

AGM Announcement

AGM Announcements

Investor Meetings

Equity Carve-outs

Credit rating assigned by r...

Investor Meetings

Earnings Conference Call

Annual Secretarial Complian...

Financial Results Publication

Related Party Transactions

External Links:

Data:

Zim Laboratories Ltd has received Marketing Authorization for Tamsulosin Hydrochloride and Dutasteride capsules in Australia, marking its second approval in the country, as announced on August 4, 2025.

AI Assistant

Zim Laboratories Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.